CIK 0001039828 · Non-accelerated filer
American National Group Inc.
Sign in to watch- Ticker
- ANG-PD
- Exchange
- NYSE
- Industry
- Life Insurance
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 421447959
- Phone
- 5152210002
- Business address
- 1201 LOUISIANA STREET, SUITE 2900, HOUSTON, TX, 77002-5607
- Former names
- AMERICAN EQUITY INVESTMENT LIFE HOLDING CO
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-09-21 | Lorenzen Jeffrey D Executive VP-Chief Inv Officer | Sale | −76,619 | $53.85 | $4.1M | 51,676 |
| 2023-09-21 | Lorenzen Jeffrey D Executive VP-Chief Inv Officer | Sale | −20,776 | $53.87 | $1.1M | 30,900 |
| 2023-09-21 | Andre Axel Chief Financial Officer | Sale | −29,273 | $53.87 | $1.6M | 13,740 |
| 2023-09-20 | Howe Robert L Director | Sale | −5,000 | $54.16 | $271K | 78,282 |
| 2023-09-20 | Bhalla Anant CEO & President | Sale | −183,202 | $54.05 | $9.9M | 1,028,134 |
| 2023-09-19 | Hamalainen James Louis EVP & Chief Investment Officer | Sale | −81,969 | $54.11 | $4.4M | 19,216 |
| 2023-09-19 | Bhalla Anant CEO & President | Sale | −92,638 | $54.12 | $5.0M | 1,028,134 |
| 2023-09-18 | Bhalla Anant CEO & President | Sale | −76,297 | $54.12 | $4.1M | 1,028,134 |
| 2023-09-15 | Hamalainen James Louis EVP & Chief Investment Officer | Sale | −68,915 | $54.03 | $3.7M | 19,216 |
| 2023-08-16 | Howe Robert L Director | Sale | −5,000 | $53.35 | $267K | 83,282 |
| 2023-08-10 | Hamalainen James Louis EVP & Chief Investment Officer | Sale | −16,048 | $53.32 | $856K | 19,416 |
| 2023-08-10 | Hamalainen James Louis EVP & Chief Investment Officer | Sale | −200 | $53.37 | $11K | 19,216 |
| 2022-08-09 | Lorenzen Jeffrey D EVP-Chief Risk Officer | Sale | −25,000 | $40.00 | $1.0M | 36,439 |
| 2022-05-16 | Neugent Gerard D. Director | Sale | −3,923 | $34.80 | $137K | 51,317 |
| 2022-05-16 | Neugent Gerard D. Director | Sale | −314 | $35.35 | $11K | 51,003 |
| 2022-04-12 | Grensteiner Ronald James Executive Vice President | Sale | −9,188 | $38.31 | $352K | 89,039 |
| 2022-03-15 | Grensteiner Ronald James Executive Vice President | Sale | −12,844 | $38.06 | $489K | 99,692 |
| 2022-03-14 | Grensteiner Ronald James Executive Vice President | Sale | −15,963 | $38.37 | $612K | 112,536 |
| 2022-03-09 | Chapman Joyce Ann Director | Sale | −3,856 | $38.26 | $148K | 51,279 |
| 2022-02-23 | Grensteiner Ronald James Executive Vice President | Sale | −10,894 | $36.03 | $392K | 112,509 |
Page 1 of 2 · 40 trades